English

ANTEX BIOLOGICS INC

EDGAR

Filing amendment (SC 13G/A) · filed 2003-03-31

26 filing records in this dataset, filed from 1997-02-25 to 2003-03-31. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

72.1 thousand USD

2001-06-30 · USD

Exact inputs and evidence

Revenue: 72094 USD Source

Operating margin

-2,524.84%

2001-06-30 · %

Exact inputs and evidence

Operating Income: -1820261 USD Source
Revenue: 72094 USD Source

Operating cash flow

-1.56 million USD

2001-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -3134531 USD Source
Operating Cash Flow: -1571044 USD Source

Free cash flow

-1.6 million USD

2001-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -3134531 USD Source
Operating Cash Flow: -1571044 USD Source
Capital Expenditure: 154931 USD Source
Capital Expenditure: 118159 USD Source

Cash and cash equivalents: 1.15 million USD 2002-09-30 Source
Exact value

1154383 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

313 thousand USD

2000-07-01 – 2001-06-30

Exact inputs and evidence

Revenue: 57093 USD · 2000-07-01 – 2000-09-30 Source
Revenue: 349612 USD · 2000-01-01 – 2000-12-31 Source
Revenue: 213964 USD · 2000-01-01 – 2000-09-30 Source
Revenue: 47865 USD · 2001-01-01 – 2001-03-31 Source
Revenue: 72094 USD · 2001-04-01 – 2001-06-30 Source

Net income

-8.34 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Net income: -6659065 USD · 2001-01-01 – 2001-12-31 Source
Net income: -5021557 USD · 2001-01-01 – 2001-09-30 Source
Net income: -2083967 USD · 2002-01-01 – 2002-03-31 Source
Net income: -2443162 USD · 2002-04-01 – 2002-06-30 Source
Net income: -2176578 USD · 2002-07-01 – 2002-09-30 Source

Capital expenditure

130 thousand USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Capital expenditure: 205091 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 164228 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 44829 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 84672 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 44829 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 88660 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 84672 USD · 2002-01-01 – 2002-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2003-03-31.

Financial data available through: 2000-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2000-12-31
Operating income: 6 of 11 periods available· newest 2000-12-31
Net income: 6 of 11 periods available· newest 2000-12-31
Operating cash flow: 4 of 11 periods available· newest 2000-12-31
Capital expenditure: 6 of 11 periods available· newest 2000-12-31
Total assets: 1 of 11 periods available· newest 2000-12-31
Total liabilities: 3 of 11 periods available· newest 2000-12-31
Current assets: 6 of 11 periods available· newest 2000-12-31
Current liabilities: 6 of 11 periods available· newest 2000-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2000-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-86.7%

Prior period

USD 2.62 million

1999-01-01 – 1999-12-31
Current period

USD 349,612

2000-01-01 – 2000-12-31

Exact inputs and evidence

349612 − 2620337 = -2270725 USD

2620337 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
349612 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ANTEX BIOLOGICS INC · 2000-12-31 ANTEX BIOLOGICS INC (edgar:893692) Year-over-year change in Revenue: -2270725 USD Concept: fundies:Revenue Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 349612 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-01-001037.txt#3753 Input fundies:Revenue: 2620337 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-01-001037.txt#3753
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 2.81 million

Prior period

−USD 3.48 million

1999-01-01 – 1999-12-31
Current period

−USD 6.3 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

-6295807 − -3483674 = -2812133 USD

-3483674 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-6295807 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ANTEX BIOLOGICS INC · 2000-12-31 ANTEX BIOLOGICS INC (edgar:893692) Year-over-year change in Net income: -2812133 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -6295807 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-02-000802.txt#7715 Input fundies:NetIncome: -3483674 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-01-001037.txt#8107
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+58.2%

Prior period

USD 191,733

1999-01-01 – 1999-12-31
Current period

USD 303,236

2000-01-01 – 2000-12-31

Exact inputs and evidence

303236 − 191733 = 111503 USD

191733 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
303236 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ANTEX BIOLOGICS INC · 2000-12-31 ANTEX BIOLOGICS INC (edgar:893692) Year-over-year change in Capital expenditure: 111503 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 303236 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-02-000802.txt#8091 Input fundies:CapitalExpenditure: 191733 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-01-001037.txt#8488
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2000 2000-01-01 – 2000-12-31

Revenue USD 349,612 100% of revenue
Operating costs Derived USD 7.4 million 2,118% of revenue
Operating income −USD 7.05 million −2,018% of revenue
Tax, interest and other Derived −USD 758,302 −217% of revenue
Net income −USD 6.3 million −1,801% of revenue

Cash

Operating cash flow −USD 5.58 million −1,596% of revenue
Capital expenditure USD 303,236 87% of revenue
Free cash flow Derived −USD 5.88 million −1,683% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 Operating loss: operating costs were 2,090% of revenue.
1996 Net income was higher than operating income, so the split is not drawn.
1997 Operating loss: operating costs were 116% of revenue.
1998 Operating loss: operating costs were 131% of revenue.
1999 Operating loss: operating costs were 238% of revenue.
2000 Operating loss: operating costs were 2,118% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1995-01-01 – 1995-12-31	153425	3205935 Derived	-3052510	78549 Derived	-3131059	-2866129 Derived	Source 1995-01-01 – 1995-12-31: 153425 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -3052510 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -3131059 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -2832752 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 33377 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	3827111	3405603 Derived	421508	-113927 Derived	535435	775689 Derived	Source 1996-01-01 – 1996-12-31: 3827111 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: 421508 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: 535435 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: 932188 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 156499 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	4755712	5502305 Derived	-746593	-303917 Derived	-442676	-1070697 Derived	Source 1997-01-01 – 1997-12-31: 4755712 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -746593 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -442676 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -867952 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 202745 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	4507029	5882965 Derived	-1375936	1457751 Derived	-2833687	Unavailable	Source 1998-01-01 – 1998-12-31: 4507029 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -1375936 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -2833687 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: 482178 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	2620337	6235635 Derived	-3615298	-131624 Derived	-3483674	Unavailable	Source 1999-01-01 – 1999-12-31: 2620337 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -3615298 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -3483674 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: 191733 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	349612	7403721 Derived	-7054109	-758302 Derived	-6295807	-5882320 Derived	Source 2000-01-01 – 2000-12-31: 349612 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -7054109 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -6295807 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -5579084 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 303236 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 349.6K 2000

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Revenue	153425	Revenue: 153425 Open source
19961996-12-31	Revenue	3827111	Revenue: 3827111 Open source
19971997-12-31	Revenue	4755712	Revenue: 4755712 Open source
19981998-12-31	Revenue	4507029	Revenue: 4507029 Open source
19991999-12-31	Revenue	2620337	Revenue: 2620337 Open source
20002000-12-31	Revenue	349612	Revenue: 349612 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-86.7% 2000

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Year over year	No prior comparable period	Revenue: 153425 Open source
19961996-12-31	Year over year	2,394.5%	Revenue: 3827111 Open source Revenue: 153425 Open source
19971997-12-31	Year over year	24.3%	Revenue: 4755712 Open source Revenue: 3827111 Open source
19981998-12-31	Year over year	-5.2%	Revenue: 4507029 Open source Revenue: 4755712 Open source
19991999-12-31	Year over year	-41.9%	Revenue: 2620337 Open source Revenue: 4507029 Open source
20002000-12-31	Year over year	-86.7%	Revenue: 349612 Open source Revenue: 2620337 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -2,017.7% 2000

Net margin -1,800.8% 2000

Free cash flow margin -1,682.5% 2000

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Operating margin	-1,989.6%	Operating Income: -3052510 Open source Revenue: 153425 Open source
19961996-12-31	Operating margin	11%	Operating Income: 421508 Open source Revenue: 3827111 Open source
19971997-12-31	Operating margin	-15.7%	Operating Income: -746593 Open source Revenue: 4755712 Open source
19981998-12-31	Operating margin	-30.5%	Operating Income: -1375936 Open source Revenue: 4507029 Open source
19991999-12-31	Operating margin	-138%	Operating Income: -3615298 Open source Revenue: 2620337 Open source
20002000-12-31	Operating margin	-2,017.7%	Operating Income: -7054109 Open source Revenue: 349612 Open source
19951995-12-31	Net margin	-2,040.8%	Net Income: -3131059 Open source Revenue: 153425 Open source
19961996-12-31	Net margin	14%	Net Income: 535435 Open source Revenue: 3827111 Open source
19971997-12-31	Net margin	-9.3%	Net Income: -442676 Open source Revenue: 4755712 Open source
19981998-12-31	Net margin	-62.9%	Net Income: -2833687 Open source Revenue: 4507029 Open source
19991999-12-31	Net margin	-132.9%	Net Income: -3483674 Open source Revenue: 2620337 Open source
20002000-12-31	Net margin	-1,800.8%	Net Income: -6295807 Open source Revenue: 349612 Open source
19951995-12-31	Free cash flow margin	-1,868.1%	Revenue: 153425 Open source Operating Cash Flow: -2832752 Open source Capital Expenditure: 33377 Open source
19961996-12-31	Free cash flow margin	20.3%	Revenue: 3827111 Open source Operating Cash Flow: 932188 Open source Capital Expenditure: 156499 Open source
19971997-12-31	Free cash flow margin	-22.5%	Revenue: 4755712 Open source Operating Cash Flow: -867952 Open source Capital Expenditure: 202745 Open source
19981998-12-31	Free cash flow margin	Not reported	Revenue: 4507029 Open source Capital Expenditure: 482178 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 2620337 Open source Capital Expenditure: 191733 Open source
20002000-12-31	Free cash flow margin	-1,682.5%	Revenue: 349612 Open source Operating Cash Flow: -5579084 Open source Capital Expenditure: 303236 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -5.6M 2000

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Operating cash flow	-2832752	Operating Cash Flow: -2832752 Open source
19961996-12-31	Operating cash flow	932188	Operating Cash Flow: 932188 Open source
19971997-12-31	Operating cash flow	-867952	Operating Cash Flow: -867952 Open source
19981998-12-31	Operating cash flow	Not reported	No source recorded
19991999-12-31	Operating cash flow	Not reported	No source recorded
20002000-12-31	Operating cash flow	-5579084	Operating Cash Flow: -5579084 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -5.9M 2000

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Free cash flow	-2866129	Operating Cash Flow: -2832752 Open source Capital Expenditure: 33377 Open source
19961996-12-31	Free cash flow	775689	Operating Cash Flow: 932188 Open source Capital Expenditure: 156499 Open source
19971997-12-31	Free cash flow	-1070697	Operating Cash Flow: -867952 Open source Capital Expenditure: 202745 Open source
19981998-12-31	Free cash flow	Unavailable	Capital Expenditure: 482178 Open source
19991999-12-31	Free cash flow	Unavailable	Capital Expenditure: 191733 Open source
20002000-12-31	Free cash flow	-5882320	Operating Cash Flow: -5579084 Open source Capital Expenditure: 303236 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

9.8% 2000

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1995-12-31	Liabilities / assets	Not reported	No source recorded
1996-12-31	Liabilities / assets	Not reported	No source recorded
1997-12-31	Liabilities / assets	Not reported	No source recorded
19981998-12-31	Liabilities / assets	Not reported	Total Liabilities: 1475158 Open source
19991999-12-31	Liabilities / assets	Not reported	Total Liabilities: 1053037 Open source
20002000-12-31	Liabilities / assets	9.8%	Total Liabilities: 1177964 Open source Total Assets: 11990397 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

9.95× 2000

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Current assets / current liabilities	0.78×	Current Assets: 1231800 Open source Current Liabilities: 1574995 Open source
19961996-12-31	Current assets / current liabilities	4.16×	Current Assets: 7562221 Open source Current Liabilities: 1817586 Open source
19971997-12-31	Current assets / current liabilities	6.09×	Current Assets: 6614749 Open source Current Liabilities: 1085497 Open source
19981998-12-31	Current assets / current liabilities	4.1×	Current Assets: 5298339 Open source Current Liabilities: 1291602 Open source
19991999-12-31	Current assets / current liabilities	2.07×	Current Assets: 1873128 Open source Current Liabilities: 904917 Open source
20002000-12-31	Current assets / current liabilities	9.95×	Current Assets: 11025533 Open source Current Liabilities: 1107670 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1995 1995-01-01 – 1995-12-31	−USD 3.13 million Exact value Exact value: -3131059 USD 1995-01-01 – 1995-12-31: -3131059 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANTEX BIOLOGICS INC · 1995-12-31 ANTEX BIOLOGICS INC (edgar:893692) Net Income: -3131059 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3131059 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-97-000594.txt#1602 The citation records this snapshot. The page link may show a newer release later.	−USD 2.83 million Exact value Exact value: -2832752 USD 1995-01-01 – 1995-12-31: -2832752 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANTEX BIOLOGICS INC · 1995-12-31 ANTEX BIOLOGICS INC (edgar:893692) Operating Cash Flow: -2832752 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2832752 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-97-000594.txt#1626 The citation records this snapshot. The page link may show a newer release later.	USD 33,377 Exact value Exact value: 33377 USD 1995-01-01 – 1995-12-31: 33377 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANTEX BIOLOGICS INC · 1995-12-31 ANTEX BIOLOGICS INC (edgar:893692) Capital Expenditure: 33377 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33377 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-97-000594.txt#1630 The citation records this snapshot. The page link may show a newer release later.	−USD 2.87 million Calculation and evidence -2832752 − 33377 USD Exact free cash flow: -2866129 USD 1995-01-01 – 1995-12-31: -2832752 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 33377 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANTEX BIOLOGICS INC · 1995-12-31 ANTEX BIOLOGICS INC (edgar:893692) Free cash flow: -2866129 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2832752 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-97-000594.txt#1626 Input fundies:CapitalExpenditure: 33377 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-97-000594.txt#1630 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	USD 535,435 Exact value Exact value: 535435 USD 1996-01-01 – 1996-12-31: 535435 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANTEX BIOLOGICS INC · 1996-12-31 ANTEX BIOLOGICS INC (edgar:893692) Net Income: 535435 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: 535435 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-98-000801.txt#1714 The citation records this snapshot. The page link may show a newer release later.	USD 932,188 Exact value Exact value: 932188 USD 1996-01-01 – 1996-12-31: 932188 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANTEX BIOLOGICS INC · 1996-12-31 ANTEX BIOLOGICS INC (edgar:893692) Operating Cash Flow: 932188 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 932188 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-98-000801.txt#1738 The citation records this snapshot. The page link may show a newer release later.	USD 156,499 Exact value Exact value: 156499 USD 1996-01-01 – 1996-12-31: 156499 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANTEX BIOLOGICS INC · 1996-12-31 ANTEX BIOLOGICS INC (edgar:893692) Capital Expenditure: 156499 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 156499 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-98-000801.txt#1742 The citation records this snapshot. The page link may show a newer release later.	USD 775,689 Calculation and evidence 932188 − 156499 USD Exact free cash flow: 775689 USD 1996-01-01 – 1996-12-31: 932188 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 156499 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANTEX BIOLOGICS INC · 1996-12-31 ANTEX BIOLOGICS INC (edgar:893692) Free cash flow: 775689 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 932188 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-98-000801.txt#1738 Input fundies:CapitalExpenditure: 156499 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-98-000801.txt#1742 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 442,676 Exact value Exact value: -442676 USD 1997-01-01 – 1997-12-31: -442676 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANTEX BIOLOGICS INC · 1997-12-31 ANTEX BIOLOGICS INC (edgar:893692) Net Income: -442676 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -442676 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-99-000879.txt#2011 The citation records this snapshot. The page link may show a newer release later.	−USD 867,952 Exact value Exact value: -867952 USD 1997-01-01 – 1997-12-31: -867952 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANTEX BIOLOGICS INC · 1997-12-31 ANTEX BIOLOGICS INC (edgar:893692) Operating Cash Flow: -867952 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -867952 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-98-000801.txt#1738 The citation records this snapshot. The page link may show a newer release later.	USD 202,745 Exact value Exact value: 202745 USD 1997-01-01 – 1997-12-31: 202745 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANTEX BIOLOGICS INC · 1997-12-31 ANTEX BIOLOGICS INC (edgar:893692) Capital Expenditure: 202745 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 202745 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-99-000879.txt#2041 The citation records this snapshot. The page link may show a newer release later.	−USD 1.07 million Calculation and evidence -867952 − 202745 USD Exact free cash flow: -1070697 USD 1997-01-01 – 1997-12-31: -867952 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 202745 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANTEX BIOLOGICS INC · 1997-12-31 ANTEX BIOLOGICS INC (edgar:893692) Free cash flow: -1070697 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -867952 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-98-000801.txt#1738 Input fundies:CapitalExpenditure: 202745 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-99-000879.txt#2041 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 2.83 million Exact value Exact value: -2833687 USD 1998-01-01 – 1998-12-31: -2833687 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANTEX BIOLOGICS INC · 1998-12-31 ANTEX BIOLOGICS INC (edgar:893692) Net Income: -2833687 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2833687 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-00-001509.txt#2067 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 482,178 Exact value Exact value: 482178 USD 1998-01-01 – 1998-12-31: 482178 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANTEX BIOLOGICS INC · 1998-12-31 ANTEX BIOLOGICS INC (edgar:893692) Capital Expenditure: 482178 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 482178 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-00-001509.txt#2097 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
1999 1999-01-01 – 1999-12-31	−USD 3.48 million Exact value Exact value: -3483674 USD 1999-01-01 – 1999-12-31: -3483674 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANTEX BIOLOGICS INC · 1999-12-31 ANTEX BIOLOGICS INC (edgar:893692) Net Income: -3483674 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3483674 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-01-001037.txt#8107 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 191,733 Exact value Exact value: 191733 USD 1999-01-01 – 1999-12-31: 191733 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANTEX BIOLOGICS INC · 1999-12-31 ANTEX BIOLOGICS INC (edgar:893692) Capital Expenditure: 191733 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 191733 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-01-001037.txt#8488 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2000 2000-01-01 – 2000-12-31	−USD 6.3 million Exact value Exact value: -6295807 USD 2000-01-01 – 2000-12-31: -6295807 USD Inspect Net Income Open source Share or cite Citation for Net Income · ANTEX BIOLOGICS INC · 2000-12-31 ANTEX BIOLOGICS INC (edgar:893692) Net Income: -6295807 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6295807 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-02-000802.txt#7715 The citation records this snapshot. The page link may show a newer release later.	−USD 5.58 million Exact value Exact value: -5579084 USD 2000-01-01 – 2000-12-31: -5579084 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ANTEX BIOLOGICS INC · 2000-12-31 ANTEX BIOLOGICS INC (edgar:893692) Operating Cash Flow: -5579084 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5579084 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-02-000802.txt#8031 The citation records this snapshot. The page link may show a newer release later.	USD 303,236 Exact value Exact value: 303236 USD 2000-01-01 – 2000-12-31: 303236 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ANTEX BIOLOGICS INC · 2000-12-31 ANTEX BIOLOGICS INC (edgar:893692) Capital Expenditure: 303236 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 303236 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-02-000802.txt#8091 The citation records this snapshot. The page link may show a newer release later.	−USD 5.88 million Calculation and evidence -5579084 − 303236 USD Exact free cash flow: -5882320 USD 2000-01-01 – 2000-12-31: -5579084 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 303236 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ANTEX BIOLOGICS INC · 2000-12-31 ANTEX BIOLOGICS INC (edgar:893692) Free cash flow: -5882320 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T19:31:38Z Snapshot: 8566d9054a7f1bf6259c00ce8ef972fa8c5d916072697e9fdc47854d894e28f3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/893692?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5579084 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-02-000802.txt#8031 Input fundies:CapitalExpenditure: 303236 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/893692/0000950133-02-000802.txt#8091 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

26 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000893692, 893692, edgar:893692

Also known as MICROCARB INC

ANTEX BIOLOGICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Capital expenditure

Where revenue goes

2000 2000-01-01 – 2000-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation